Table of Contents
Washington University Experience | NEOPLASMS (HEMATOLYMPHOID) | Lymphoma, primary | 3C1 Lymphoma (Case 3) 1 CD 20 4 (4X)
3C1,2 Immunohistochemical studies reveal tumor cells to be diffusely positive for the B-cell marker CD20.